877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Polycyclic organic compounds, Six-membered rings, Experimental cancer drugs

Categories

Antineoplastic and immunomodulating drugs (4)
Antineoplastic drugs (4)
Cyclic compounds (4)
Heterocyclic compounds (3)
Heterocyclic compounds (4 or more rings) (3)
Organic peroxides (3)
Trioxanes (3)
Pharmaceuticals (2)
Cycloalkanes (1)
Cyclopropanes (1)
Halides (1)
Organofluorides (1)
Organohalides (1)
Piperazines (1)
Tetracyclic compounds (1)
Three-membered rings (1)

Suppliers

Matrix Scientific (1)

artemisinin (63968-64-9)  
qinghaosu  ·  quinghaosu  ·  artemisinine
Artemisinin, also known as qinghao su (Chinese: 青蒿素), and its semi-synthetic derivatives are a group of drugs used against Plasmodium falciparum malaria. It was discovered by Tu Youyou, a Chinese scientist, who was awarded half of the 2015 Nobel Prize in Medicine for her discovery. Treatments containing an artemisinin derivative (artemisinin-combination therapies, ACTs) are now standard treatment worldwide for P.
AC1LD383 (63968-64-9)  
Artemisinin, also known as qinghao su (Chinese: 青蒿素), and its semi-synthetic derivatives are a group of drugs used against Plasmodium falciparum malaria. It was discovered by Tu Youyou, a Chinese scientist, who was awarded half of the 2015 Nobel Prize in Medicine for her discovery. Treatments containing an artemisinin derivative (artemisinin-combination therapies, ACTs) are now standard treatment worldwide for P.
Zosuquidar Trihydrochloride (167465-36-3)  
Zosuquidar (also LY-335979) is an experimental antineoplastic drug. In 2010, it was announced that a phase III trial for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome did not meet its primary endpoint and Eli Lilly discontinued its development. Zosquidir inhibits P-glycoproteins.
Related searches
Polycyclic organic compounds
Six-membered rings
Experimental cancer drugs